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Abstract
Aims: We sought to analyse local distribution of aortic annulus and left ventricular outflow tract (LVOT) 
calcification in patients undergoing transcatheter aortic valve replacement (TAVR) and its impact on aortic 
regurgitation (AR) immediately after device placement. 
Methods and results: A group of 177 patients with severe aortic stenosis undergoing multislice computed 
tomography of the aortic root followed by TAVR were enrolled in this single-centre study. Annular and LVOT 
calcifications were assessed per cusp using a semi-quantitative grading system (0: none; 1 [mild]: small, 
non-protruding calcifications; 2 [moderate]: protruding [>1 mm] or extensive [>50% of cusp sector] calcifi-
cations; 3 [severe]: protruding and extensive calcifications). Any calcification of the annulus or LVOT was 
present in 107 (61%) and 63 (36%) patients, respectively. Prevalence of annulus/LVOT calcifications in the 
left coronary cusp was 42% and 25%, respectively, in the non-coronary cusp 28% and 13%, in the right coro-
nary cusp 13% and 5%. AR grade 2 to 4 assessed by the method of Sellers immediately after TAVR device 
implantation was observed in 55 patients (31%). Multivariate regression analysis revealed that the overall 
annulus calcification (OR [95% CI] 1.48 [1.10-2.00]; p=0.0106), the overall LVOT calcification (1.93 [1.26-
2.96]; p=0.0026), any moderate or severe LVOT calcification (5.37 [1.52-18.99]; p=0.0092), and asymmetric 
LVOT calcification were independent predictors of AR.
Conclusions: Calcifications of the aortic annulus and LVOT are frequent in patients undergoing TAVR, and 
both the distribution and the severity of calcifications appear to be independent predictors of aortic regurgita-
tion after device implantation. 
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Introduction
The presence of calcifications is a characteristic finding of degen-
erative aortic valve stenosis which becomes more pronounced with 
advanced disease stages. Among patients undergoing transcathe-
ter aortic valve replacement (TAVR), aortic valve calcification has 
been identified as a predictor of paravalvular regurgitation after 
device placement1-10. However, little is known about the spatial dis-
tribution of aortic valve calcifications on the annular and particu-
larly the left ventricular outflow tract (LVOT) level as well as its 
Editorial, see page 659
clinical impact. Current devices anchor and seal within the annu-
lus and LVOT, and therefore localised calcifications within these 
regions may play an important role and may affect the procedural 
outcome. Therefore, the aim of this study was to assess systemati-
cally the extent, distribution, and localisation of annulus and LVOT 
calcifications in patients undergoing TAVR and to analyse their 
impact on the frequency and severity of immediate aortic regurgita-
tion (AR) after device implantation. 
Methods
PATIENT POPULATION
A consecutive group of patients with severe aortic stenosis eval-
uated for TAVR by multislice computed tomography (MSCT) 
imaging of the aortic root and subsequent TAVR procedure were 
enrolled in this single-centre observational study between October 
2007 and March 2012. All patients had an increased surgical risk 
or were deemed inoperable due to significant pre-existing clini-
cal conditions and comorbidities. The assessment was performed 
by the institutional Heart Team and the decision to perform TAVR 
based on a consensus. All patients provided written informed con-
sent to be included in both the local and national TAVR registries 
which were approved by the local ethics committee.
IMAGING TECHNIQUE 
MSCT assessment of the aortic root was performed on either 
a Siemens SOMATOM Sensation Cardiac 64 scanner with a slice 
collimation of 1.5 mm, or a Siemens SOMATOM Definition Flash 
Dual Source scanner with a slice collimation of 0.6 mm, tube 
voltage of 100 or 120 kV and tube current according to patient 
size (Siemens Medical Solutions, Inc., Forchheim, Germany). All 
patients underwent contrast-enhanced MSCT scanning with retro-
spective ECG gating and received an intravenous injection of 80 to 
120 ml of contrast medium via the antecubital vein at a flow rate 
of 5 ml/s. Automated peak enhancement detection in the descend-
ing aorta at the level of the diaphragm with a threshold of 100 
Hounsfield units was used for timing of the scan. Images were 
reconstructed in the diastolic phase at 60% of the RR interval.
Images were processed offline at a dedicated workstation using 
the semi-automated 3mensio tool (3mensio Medical Imaging BV, 
Bilthoven, The Netherlands). After automated segmentation of the 
aortic root, the annular plane was manually identified in a perpen-
dicular short-axis view, defined as the plane connecting the nadirs 
of the three aortic cusps. The LVOT plane was defined as a plane 
perpendicular to the centre line 5 mm below the annular plane11. 
The analyses were performed by an experienced observer who was 
blinded to clinical and echocardiographic as well as procedural data.
DEFINITION OF CALCIFICATION GRADING
The degree of calcification was graded at both the annular and the 
LVOT level, and assessed per cusp sector. The extent of the vir-
tual cusp sector in the annular and LVOT plane was defined by 
the actual extent of the corresponding cusp and named accordingly 
(Figure 1). The calcification was semi-quantitatively graded as fol-
lows: grade 0 - no calcification, grade 1 - small, non-protruding 
calcifications, grade 2 - protruding (>1 mm) or extensive (>50% 
of cusp sector) calcifications, grade 3 - protruding (>1 mm) and 
extensive (>50% of cusp sector) calcifications (Table 1). Grading 
examples are displayed in Figure 1, representative of both the annu-
lar and the LVOT plane. “Any calcification” was defined as the 
presence of calcification grade 1-3 in at least one of the three cusp 
sectors within the annulus and the LVOT, respectively. “Overall 
calcification” was defined as the sum of all three cusp sectors in 
a particular level. The overall valve calcification including leaflets 
was visually graded per cusp as none=0, mild=1, moderate=2 and 
severe=3, and was derived from the 3D MSCT reconstruction of the 
aortic root in the maximum intensity projection.
Figure 1. Examples of annulus/LVOT calcification types. A) Mild calcification of left coronary sector, absence of calcifications in non and 
right coronary sectors (type 1/0/0). Dotted lines indicate cusp sectors, which are identified from a parallel valvular plane. B) Moderate 
calcification of left coronary sector, absence of calcifications in non and right coronary sectors (2/0/0). C) Severe calcification of non-
coronary sector, absence of calcifications in left and right coronary sectors (0/3/0). LVOT: left ventricular outflow tract
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ASSESSMENT OF POST-IMPLANT AORTIC REGURGITATION
AR was assessed immediately after implantation of the TAVR pros-
thesis by means of a standardised supra-aortic angiography using 
contrast dye injection through a 5 Fr pigtail catheter (40 ml at 15 
to 20 ml/sec) positioned 1.5-2 cm above the aortic valve in a poste-
rior-anterior or right anterior-oblique projection, based on the criteria 
established by Sellers. Patients with no and mild AR (grade 0 and 1) 
and patients with more than mild AR (grade 2-4) were grouped in 
two cohorts and compared with regard to baseline clinical charac-
teristics, echocardiographic status and MSCT geometric character-
istics as well as differences in calcification patterns. The endpoint of 
immediate post-implant AR instead of final post-procedural AR was 
intentionally selected to allow for identification of anatomic char-
acteristics which predict suboptimal immediate device performance. 
STATISTICAL ANALYSIS
Categorical variables are presented as counts with percentages 
(p-values from chi-square or Fisher’s tests), continuous variables as 
means with standard deviations (p-values from t-tests), or as medians 
and 25%-75% interquartile ranges (p-values from Mann-Whitney U 
tests). Calcification effects on AR after implantation (moderate or 
severe coded 1, none or mild coded 0) were analysed using logis-
tic regressions and graphically presented as probabilities (95% confi-
dence interval [CI]) with the model fitted line. There was no evidence 
of differential calcification effects on AR comparing the three differ-
ent cusps (all pairwise comparisons of effects sizes p>0.18), so the 
calcification grades of the three cusps were aggregated or summed 
as appropriate for the final analyses (e.g., any calcification means 
at least one cusp with mild, moderate or severe calcification; e.g., 
overall calcification means the grade of the three cusps added). To 
assess the potential effect of asymmetric cusp calcification, we also 
estimated the effect of the difference in the calcification grade among 
the three cusps (≥1 or ≥2 grade difference between the three cusps). 
Models were compared using Akaike’s Information Criterion (AIC; 
presented with odds ratios [OR] 95% CI), corrected for valve calci-
fication, device implantation height and device to annulus ratio. All 
statistical analyses were performed with Stata 12.1 (StataCorp LP, 
College Station, TX, USA).
Results
A total of 188 patients (mean age 82.2±5.8 years, STS predicted 
risk of mortality 6.1±3.9) were screened for inclusion in the study. 
Eleven patients were excluded because of insufficient MSCT 
Table 1. Definition of cusp-specific annulus and LVOT calcification 
grading.
Grade 0 No calcification
Grade 1 (mild) Small, non-protruding calcification
Grade 2 (moderate) Protruding (>1 mm) or extensive (>50% of 
cusp sector) calcification
Grade 3 (severe) Protruding (>1 mm) and extensive (>50% of 
cusp sector) calcification
LVOT: left ventricular outflow tract
imaging quality due to respiration artefacts which did not allow for 
a precise delineation of calcifications and corresponding cusp sec-
tors. Therefore, the overall study population comprised 177 patients. 
Baseline patient characteristics are presented in Table 2.
Calcification distribution
Any calcifications of the aortic valve were observed in 174 patients 
(98%). Calcifications of the annulus and LVOT were observed in 107 
(61%) and 63 (36%) patients, respectively. More than mild calcifica-
tions were present in 29 (16%) patients within the annulus and 13 
(7%) patients within the LVOT. Calcifications were most frequently 
located within the left coronary cusp with a prevalence of 42% for the 
annulus and 25% for the LVOT, followed by the non-coronary cusp 
(28%/13%) and the right coronary cusp (13%/5%) (Figure 2).
Procedural characteristics and results
TAVR was performed using the transfemoral access in 145 patients 
(82%), transapical in 29 (16%) and subclavian access in three 
patients (2%). Device success according to the VARC-2 definition 
was achieved in 96.6% of patients. The self-expanding Medtronic 
CoreValve (Medtronic, Minneapolis, MN, USA) prosthesis was 
implanted in 112 patients (63%), whereas the Edwards SAPIEN/
SAPIEN XT (Edwards Lifesciences, Irvine, CA, USA) prosthesis 
was implanted in 65 patients (37%). AR grade 2 to 4 immediately 
after TAVR was observed in 55 patients (31%), which resulted in post-
dilation in 50 and implantation of a second device in five patients. The 
final grade of AR was 0 in 41 (23%), 1 in 95 (54%), 2 in 39 (22%) 
and 3 in two patients (1%). Comparing patients with and without AR 
of grade 2 to 4 immediately after TAVR, there were no differences in 
terms of the device used (p=0.157), implantation depth at the non-cor-
onary (6.1±3.2 mm vs. 5.4±2.9 mm; p=0.151) and left coronary cusp 
level (6.6±3.5 mm vs. 6.3±3.2 mm; p=0.562), pre-procedural aortic 
valve area (0.6±0.2 cm2 vs. 0.6±0.2 cm2; p=0.174) and left ventricular 
Annulus
LVOT
1.1 57.1
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Figure 2. Prevalence of annulus and LVOT calcifications according 
to location and severity in percent. LCC: left coronary cusp; 
LVOT: left ventricular outflow tract; NCC: non-coronary cusp; 
RCC: right coronary cusp
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ejection fraction (48.8±15.2% vs. 52.9±15.5%; p=0.105). Patients 
with AR grade 2-4 had a larger annulus (perimeter: 78.7±6.9 mm vs. 
72.9±6.4 mm; p<0.001; area: 475.8±84.1 mm2 vs. 409.9±72.6 mm2; 
p<0.001) at baseline and the TAVR prosthesis was less oversized 
(11.6±11.4% vs. 13.7±10.0%; p=0.001). 
Impact of calcification on post-implant aortic 
regurgitation
Table 3 shows the distribution of annulus and LVOT calcification 
in patients with and without grade 2-4 post-implant aortic regurgi-
tation. The overall calcification extent at both the annulus and the 
LVOT level was higher among patients with moderate to severe AR 
as opposed to patients with none or mild AR, with a positive asso-
ciation between overall calcification extent and prevalence of AR 
(Figure 3). There was a significant difference in the severity of cal-
cification for the non-coronary cusp location between both groups, 
but no significant differences for the left and right coronary cusp 
locations for both the annular and the LVOT level (Table 3). Within 
the LVOT, the presence of any calcification as well as any moder-
ate to severe calcification was higher among patients with more 
than mild AR compared to those with none to mild AR. Within the 
annulus, we observed a similar trend without reaching conventional 
levels of statistical significance. Multivariate regression analysis 
revealed that the overall annulus calcification (OR [95% CI] 1.48 
[1.10-2.00]; p=0.0106), the overall LVOT calcification (1.93 [1.26-
2.96]; p=0.0026), any moderate or severe LVOT calcification (5.37 
[1.52-18.99]; p=0.0092), and asymmetric LVOT calcification were 
independent predictors of moderate to severe AR (Table 4).
Discussion
Our study demonstrates that calcifications within the annulus and 
LVOT are frequently observed in patients with severe aortic valve 
stenosis undergoing TAVR, and that both severity and distribution 
of calcification within the annulus and LVOT have a significant 
impact on the risk of significant aortic regurgitation immediately 
after TAVR prosthesis implantation. 
Calcification of the aortic root assumes a central role in the 
pathophysiological process underlying degenerative aortic valve 
stenosis. The degenerative process typically begins and progresses 
within the leaflets, but may extend into surrounding regions dur-
ing a later disease stage. Rosenhek and colleagues12 have proposed 
a grading system for aortic valve calcifications based on transtho-
racic echocardiographic findings (no calcification; mildly calci-
fied [small isolated spots]; moderately calcified [multiple larger 
spots]; heavily calcified [extensive thickening and calcification of 
all cusps]), which has been accepted as a semi-quantitative tool to 
describe the overall amount of aortic valve calcification. 
The advent of advanced imaging techniques such as MSCT has 
improved detection of aortic valve calcifications and allows for 
a quantitative analysis of the extent and distribution of calcifica-
tions13,14. Several studies have identified calcification of the aortic 
valve as an independent predictor of aortic regurgitation, the need 
Table 2. Baseline patient characteristics.
Total
N=177
Aortic regurgitation after implantation
None or mild
n=122
Moderate or severe
n=55
p-value
Age (years) 82.2±5.8 82.9±4.3 81.5±7.4 0.123
Female gender, n (%) 97 (55%) 74 (61%) 23 (42%) 0.023
Body mass index (kg/m²) 25.8±4.8 25.9±4.8 24.9±3.8 0.186
Cardiac risk 
factors
Diabetes mellitus, n (%) 49 (28%) 35 (29%) 14 (25%) 0.719
Hypercholesterolaemia, n (%) 107 (61%) 73 (60%) 34 (62%) 0.869
Hypertension, n (%) 134 (76%) 93 (76%) 41 (75%) 0.851
Current smoker, n (%) 22 (12%) 13 (11%) 9 (16%) 0.327
Past medical 
history
Coronary artery disease, n (%) 120 (68%) 75 (61%) 35 (64%) 0.868
Previous myocardial infarction, n (%) 27 (15%) 19 (16%) 8 (15%) 1.000
Previous coronary artery bypass graft, n (%) 31 (18%) 22 (18%) 9 (16%) 0.835
Previous percutaneous coronary intervention, n (%) 47 (27%) 31 (25%) 16 (29%) 0.713
Previous stroke, n (%) 15 (9%) 10 (8%) 5 (9%) 1.000
Peripheral vascular disease, n (%) 30 (17%) 20 (16%) 10 (18%) 0.829
Atrial fibrillation, n (%) 52 (29%) 37 (31%) 15 (28%) 0.858
Chronic obstructive pulmonary disease, n (%) 28 (16%) 15 (12%) 13 (24%) 0.073
Renal dysfunction (eGFR <60 ml/min/1.73 m²) 119 (67%) 83 (68%) 36 (65%) 0.733
Pulmonary artery hypertension* 53 (30%) 35 (29%) 18 (33%) 0.594
Risk 
assessment
Logistic EuroSCORE (%) 23.3±13.2 23.4±14.4 23.3±10.6 0.958
STS score (%) 6.1±3.9 6.3±4.3 5.9±3.3 0.490
*Systolic peak pulmonary pressure >60 mmHg.
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for post-dilation, the need for pacemaker implantation, and the risk 
of annulus rupture in patients undergoing TAVR1,2,7-10,15,16. While 
these findings are well established for the overall extent of valve 
calcification, little is known about the spatial distribution of cal-
cifications within the different levels of the aortic root, including 
Table 3. Annulus and LVOT calcification according to aortic 
regurgitation immediately after TAVR.
Aortic regurgitation after implantation
None or mild
n=122
Moderate or 
severe
n=55
p-value
Aortic annulus
Non-coronary cusp 0.013
none 95 (78%) 33 (60%)
mild 25 (20%) 17 (31%)
moderate 2 (2%) 5 (9%)
severe 0 (0%) 0 (0%)
Left coronary cusp 0.471
none 74 (61%) 27 (49%)
mild 34 (28%) 18 (33%)
moderate 13 (11%) 9 (16%)
severe 1 (1%) 1 (2%)
Right coronary cusp 0.177
none 110 (90%) 44 (80%)
mild 11 (9%) 10 (18%)
moderate 1 (1%) 1 (2%)
severe 0 (0%) 0 (0%)
Any calcification 68 (56%) 39 (71%) 0.068
Any moderate or severe 
calcification 17 (14%) 13 (24%) 0.131
Overall grade 1 (0-1) 1 (0-2) 0.008
LVOT
Non-coronary cusp 0.011
none 112 (92%) 43 (78%)
mild 10 (8%) 8 (15%)
moderate 0 (0%) 3 (5%)
severe 0 (0%) 1 (2%)
Left coronary cusp 0.109
none 96 (79%) 36 (65%)
mild 22 (18%) 14 (25%)
moderate 4 (3%) 5 (9%)
severe 0 (0%) 0 (0%)
Right coronary cusp 0.255
none 118 (97%) 51 (93%)
mild 4 (3%) 3 (5%)
moderate 0 (0%) 1 (2%)
severe 0 (0%) 0 (0%)
Any calcification 34 (28%) 29 (53%) 0.002
Any moderate or severe 
calcification 4 (3%) 9 (16%) 0.004
Overall grade 0 (0-1) 1 (0-1) 0.004
LVOT: left ventricular outflow tract
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
0 1 2 3 4 5 6 9
Overall calcification grade
Pr
ev
al
en
ce
 o
f m
od
er
at
e/
se
ve
re
 A
R
n=70 56 34 11 5 0 1 0
Association of annulus calcification and AR
p=0.003
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
0 1 2 3 4 5 6 9
Overall calcification grade
Pr
ev
al
en
ce
 o
f m
od
er
at
e/
se
ve
re
 A
R
n=114 41 38 3 5 0 0 0
Association of LVOT calcification and AR
p=0.000
Figure 3. Association of annulus and left ventricular outflow tract 
calcification and post-implantation aortic regurgitation. AR: aortic 
regurgitation
the LVOT, the annulus, the aortic leaflets, the sinus of Valsalva, 
the sinotubular junction and the adjacent ascending aorta, and their 
clinical impact. Based on geometric considerations, calcifications 
above the leaflets are irrelevant for device performance in patients 
Table 4. Multivariate analysis of annulus and LVOT calcification 
and impact on AR immediately after TAVR.
Annulus
0.2 1.0 5.0
Overall calcification
Calcification any moderate or severe
Difference in calcification grade cusps ≥1
Difference in calcification grade cusps ≥2
LVOT
Overall calcification
Calcification any moderate or severe
Difference in calcification grade cusps ≥1
Difference in calcification grade cusps ≥2
AR: aortic regurgitation; LVOT: left ventricular outflow tract
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undergoing TAVR. Calcifications within the leaflets interact with 
the device, but are typically displaced into the sinus which is 
unproblematic in case of a sufficiently large coronary sinus. Leaflet 
calcifications are unlikely to cause AR if the anchoring and sealing 
remains complete within the annulus or LVOT, which is the act-
ing principle of currently available TAVR devices. Conversely, we 
hypothesised that calcifications within the annulus and LVOT may 
be relevant predictors of AR immediately after TAVR with cur-
rently used devices as they impair complete sealing. Based on the 
classification proposed in this manuscript, we were able to analyse 
the frequency, extent, distribution and impact of local calcification 
within the annulus and LVOT among patients with severe aortic 
valve stenosis undergoing TAVR. 
Frequency and spatial distribution of aortic 
valve calcification 
Aortic annulus calcification is frequent and was observed in approxi-
mately two-thirds of patients undergoing TAVR in the present study. 
In one-third of the overall population, these calcifications further 
extended into the LVOT. These findings partially corroborate an ear-
lier report by Rivard et al17, who analysed 33 patients with severe 
aortic valve stenosis, in whom annular calcifications were present 
in all analysed subjects, while LVOT calcifications extending into 
the membranous part of the interventricular septum were present in 
36% and towards the anterior mitral leaflet in 42% of patients. The 
fact that one third of patients in our study did not present with annu-
lar calcifications may be surprising, but is largely the result of the 
new imaging precision provided by modern visualisation tools which 
help in the clear separation of different aspects of the aortic root in an 
unsurpassed way. With this imaging precision, calcifications within 
the leaflets, which were present in all but three patients, can be nicely 
distinguished from calcifications within the annulus and LVOT.
Impact of annulus and LVOT calcification on 
aortic regurgitation after TAVR
Local calcifications within the annulus and even more importantly 
within the LVOT increase the risk of post-implant AR. Three recent 
studies of 55 to 105 TAVR patients10,18,19, with focus on annular cal-
cifications graded semi-quantitatively, demonstrated an association 
between overall annular calcification and post-procedural AR. Our 
data in 177 patients with utilisation of a cusp-specific classification 
system not only confirm but importantly extend these findings, and 
specific spatial distribution patterns were found highly predictive of 
AR immediately after TAVR. In the present study, the sum of calcifi-
cations of the annulus as well as the LVOT emerged as independent 
predictors of more than mild AR immediately after implantation of 
a TAVR device. Moreover, we observed that calcifications located in 
the LVOT as opposed to the annulus played a more important role, 
and that grade 2 and 3 (moderate and severe) calcifications and asym-
metric calcifications within the LVOT were associated with a 2.5 to 
5.4-fold increased risk of significant AR immediately after prosthe-
sis implantation. In addition, the severity of calcification of the non-
coronary cusp location was associated with significant AR directly 
after TAVR device implantation. It therefore appears prudent during 
the TAVR screening process to focus not only on overall valve calci-
fication but also on the spatial distribution of calcifications in the aor-
tic root and particularly within the annulus and LVOT region, which 
independently predicts immediate post-procedural AR. Larger stud-
ies are required to evaluate reliably the impact of localised calcifica-
tions on additional rare events such as annulus and LVOT rupture. 
However, the understanding of various calcification patterns and 
the given calcification distribution in a particular patient may guide 
device selection and sizing in daily clinical practice, resulting in an 
improved and predictable procedural outcome. 
Limitations
This study consists of a selective TAVR population, and the results 
in terms of extent and distribution of calcifications may not be 
extrapolated to the overall population of patients with aortic valve 
stenosis. According to local standard, the majority of TAVR proce-
dures were performed with conscious sedation without periproce-
dural transoesophageal echocardiographic guidance. Therefore, AR 
after implantation of the TAVR prosthesis was assessed by aortic 
root angiography using the established criteria suggested by Sellers 
in 1964, which is known to be less sensitive and precise than echo-
cardiography. However, this strategy reflects current common prac-
tice in many experienced TAVR sites. As angiographic assessment 
of AR does not allow differentiation between paravalvular and 
valvular AR, these two entities were not separately considered in 
the analysis. This paper did not focus on leaflet calcifications, but 
on annular and LVOT calcifications. However, the overall extent 
of valve calcification semi-quantitatively assessed, similar to the 
Rosenhek score14, has been considered in the multivariate predic-
tor analysis. Finally, the number of patients with more than mild 
calcifications in the annulus and particularly the LVOT is small 
in this study, which might affect the analysis and limit the data 
interpretation.
Impact on daily practice
Calcifications of the aortic annulus and left ventricular outflow 
tract are frequent in patients undergoing TAVR, and both the 
distribution and the severity of calcifications appear to be inde-
pendent predictors of aortic regurgitation immediately after 
device implantation. Therefore, pre-procedural TAVR screening 
should include a detailed calcification assessment not only of 
the leaflets but also of the annulus and particularly the left ven-
tricular outflow tract, and results may guide device type and size 
selection.
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